The Russian pharmaceutical market has seen a significant decrease in the proportion of substandard drugs, according to a report by Roszdravnadzor. This was stated by the head of the department, Alla Samoilova, speaking at the second Russia-Africa summit.
She pointed out that every year they see a progressive reduction in the percentage of inferior medications present in the overall regulation framework. This implies that the quality is consistently getting better with each passing year.
